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Peter Arvan1 and Stephanie Fish2
On behalf of the American Thyroid Association An-nual Meeting Program Committee, it is our pleasure to
welcome you to join us at the 86th American Thyroid As-
sociation annual meeting to be held at the Sheraton Denver
Downtown Hotel on September 21–25, 2016. The program
committee has organized an integrated four-day program,
combining recent highlights in basic and clinical thyroidology,
with plenary lectures, thematic symposia, and a combination
of discussion-debates and meet-the-professor sessions. At-
tendees are encouraged to take full advantage of the breadth
of the program in order to get a snapshot of progress in the
clinical management of thyroid diseases and cutting-edge
advances in science.
Our pre-meeting gathering starts on Wednesday morn-
ing with the ATA Advanced Endocrine Neck Ultrasound
Course running concurrently with the E. Chester Ridgway
Trainee Conference for clinical, surgical, pediatric endo-
crine, and basic science trainees. That evening, the meeting
officially begins with the opening symposium, chaired by
Dr. Sheue-yann Cheng, entitled ‘‘Thyroid Breaking News.’’
This session features an overview on intriguing new findings
presented by Drs. Anthony Hollenberg, V. Krishna Chatter-
jee, and Ian Hay—running the spectrum from very basic
thyroid biological science to clinical views about the current
management of thyroid cancer.
Our Thursday morning schedule opens with a plenary
lecture from Dr. Charna Dibner, who is working at the novel
intersection between circadian rhythms, thyroid physiology,
and cancer. This will be followed by simultaneous sympo-
sia: one that will honor the legacy of Dr. Peter Laurberg, and
a second that will focus on the most appropriate treatment
of low-risk thyroid cancer. Friday morning will start with a
plenary lecture from Nobel Laureate Dr. Thomas Cech who
will explain the incredible new power of genome editing
technology for both scientific and clinical applications. This
will be followed by symposia highlighting the translational
biology of iodothyronine deiodinases and the Arthur Bauman
Symposium analyzing the growing connections between
thyroid status, feeding behavior, and obesity. A highlight of
Friday’s schedule is a session that will feature the cutting-
edge work supported by ATA research grants. Our Saturday
morning schedule starts with the Van Meter award lecture
(as is our tradition, the identity of the speaker is a surprise!).
Later that day, there will be several symposia, with topics
including the use of radioactive iodide for treatment of
thyroid cancer, discoveries in thyroid development, and
a true basic-clinical cross-sectional symposium on transla-
tional thyroid biology. Finally, a very interesting Sunday
morning schedule explores the thyroid cancer-immunity
nexus, and closes with the always-engaging thyroid tumor
board session.
Our named lecture series this year will feature eminent
leaders in the field of thyroidology, with Dr. Nancy Carrasco
giving the Sidney Ingbar Distinguished award lecture, Dr. P.
Reed Larsen giving the Lewis E. Braverman Distinguished
award lecture, Dr. Elizabeth Pearce giving the Clark T. Sawin
historical vignette, and Dr. Mingzhao Xing presenting the
Paul Starr award lecture.
Each year, some of the most interesting presentations
emerge at the posters and oral abstracts. Such sessions
populate the schedule on each full day of the meeting, and
this is a rare opportunity to have a direct dialog with sci-
entists and clinicians at all levels of the training spectrum.
Your active participation in these sessions is encouraged,
as it enhances the vitality and continued success of the
ATA meeting.
To promote dialog among colleagues further, the ATA
meeting will feature multiple thematic discussion and/or
debate sessions, including topics on thyroid surgery, cancer
stem cells, thyroid eye disease, hyper- and hypo-thyroidism
treatments, thyroid cancer pathogenesis, the hypothalamic–
pituitary–thyroid axis, thyroid autoimmunity, thyroid nod-
ules, thyroid diseases in pregnancy, thyroid ethical dilemmas,
thyroid hormonogenesis, thyroid hormone metabolites, and
endocrine disruptors. We also welcome the participation
of the Society of Nuclear Medicine and Molecular Imaging
(SNMMI) in co-sponsored sessions with ATA/SNMMI
members to discuss the utility of pre-treatment thyroid
scans and the use of 131I in the treatment of distant thyroid
cancer metastases.
In addition to these interesting discussion sessions, the
meeting offers ample time for informal interaction and
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networking with colleagues and trainees in basic and
clinical thyroidology, endocrinology, surgery, medical
oncology, nuclear medicine, and pathology. We encourage
you to seek each other out at our kick-off networking re-
ception, at the ATA annual banquet, or at scheduled breaks
in the program.
Additional opportunities for education and information
are available during the ATA meeting, including engage-
ment with pharmaceutical, device, and technology spon-
sors at the 2016 Thyroid EXPO. For further information
about the 86th Annual Meeting of the ATA, visit www
.thyroid.org
Most of all, September offers perfect fall weather in
Denver, with bright sunny days and cool clear nights, so there
are ample ways to enrich your experience. We look forward
to seeing you at the 86th annual meeting of the ATA!
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